What are Chemed's main competitors?
Chemed Corporation operates across two distinct business segments, each facing dedicated industry rivals. Within its VITAS Healthcare hospice division, its primary competitors include major national and regional hospice providers, non-profit healthcare networks, and specialized home health organizations. Within its Roto-Rooter service segment, primary competitors encompass national plumbing franchises, local emergency repair companies, commercial facility maintenance providers, and independent regional contractors vying for residential and commercial service contracts.
Related FAQs
Chemed Corporation is a diversified operational enterprise that manages prominent subsidiary companies operating primarily in specialized healthcare and residential services, most notably VITAS Healthcare (the largest provider of hospice care in the ...
Chemed Corporation records annual revenues scaling approximately between USD 2.5 billion and USD 2.6 billion, driven by the robust performance of its two primary operating divisions: VITAS Healthcare and Roto-Rooter.
Chemed Corporation belongs to the Healthcare sector.
Wall Street analyst consensus price targets for Chemed Corporation (NYSE: CHE) average approximately $610.00, reflecting positive outlooks from healthcare and service sector researchers.
The corporate brand name Chemed (referring to Chemed Corporation) originated historically as a portmanteau abbreviation combining linguistic elements of Chemical and Medical enterprises during its early corporate evolution.
Equity research analysts project steady long-term growth prospects for Chemed Corporation, anchored by the consistent operational performance of its two primary operating segments: VITAS Healthcare and Roto-Rooter.
Chemed Corporation provides specialized, non-acute healthcare services through its primary operating subsidiary, Vitas Healthcare, which is the nation's largest provider of hospice care in the United States.
Chord Energy Corporation demonstrates strong operational and financial performance, highlighted by recent quarterly earnings reports that significantly surpassed Wall Street consensus estimates for both earnings per share and total revenues.
Chemed Corporation (NYSE: CHE) trades at $540.57 per share.
Identifying three specific equities to purchase at any given moment requires balancing robust fundamental growth drivers, solid balance sheets, and competitive market positioning across diverse economic sectors.
Chemed Corporation trades at a price-to-earnings ratio of approximately 22.5 to 24.6, sitting comfortably below its 10-year historical average.
Chemed Corporation officially finalized its acquisition of VITAS Healthcare Corporation on February 24, 2004.
Chemed Corporation is a diversified operational holding company headquartered in Cincinnati, Ohio, that manages two core wholly-owned subsidiary enterprises.